Similar articles

• Nephrotic syndrome in procainamide induced lupus nephritis.

  Zech P, Colon S, Labeeuw M, Bernheim J, Blanc-Brunat N. Zech P, et al. Clin Nephrol. 1979 Apr;11(4):218-21. Clin Nephrol. 1979. PMID: 455820
• [Symposium on renal involvement in systemic diseases. III. Lupus erythematosus. Supplement: the study on lupus nephritis. Serial renal biopsies especially in the patients with non-renal SLE (author's transl)].

  Higashi F, Fujimori I. Higashi F, et al. Nihon Naika Gakkai Zasshi. 1979 Oct 10;68(10):1262-74. Nihon Naika Gakkai Zasshi. 1979. PMID: 533801 Japanese. No abstract available.
• Lupus nephritis: clinicopathological correlations.

  Ian Smeeton WM, Doak PB, Simpson IJ, Herdson PB. Ian Smeeton WM, et al. N Z Med J. 1983 Jan 26;96(724):39-42. N Z Med J. 1983. PMID: 6337351
• [Role of various drugs in the activation of systemic lupus erythematosus].

  Alarcón Segovia D. Alarcón Segovia D. Rev Invest Clin. 1966 Jul-Dec;18(3):445-66. Rev Invest Clin. 1966. PMID: 4867683 Review. Spanish. No abstract available.
• Vascular complications in lupus nephritis and lupus-like syndromes.

  Seshan SV. Seshan SV. Wien Klin Wochenschr. 2000 Aug 25;112(15-16):687-91. Wien Klin Wochenschr. 2000. PMID: 11020958 Review. No abstract available.